Metacare

Metacare

Metacare originated in 2009 as Chorokbaem Healthcare, a diversification pivot for the Seoul-based Chorokbaem Group, a publicly listed entity historically known for K-drama production and media. Won Young-sik, the Group's Chairman, provides strategic direction, while Metalabs Co., Ltd. holds a controlling 33.21% equity stake, binding Metacare to the broader corporate ecosystem rather than operating as a standalone fund. The firm's investment strategy centers on direct buyouts within healthcare services and related real estate. Metacare owns the Jeju Hospital, a commercial medical facility on Jeju Island, and a commercial land and building property in Daegu. Its cross-border posture is visible in two hospital projects — one in China and one in India — signaling a willingness to export Korean healthcare operational models into high-growth Asian markets. The focus remains physical infrastructure and operating assets, not venture-stage therapeutics or medical devices. Metacare has not publicly disclosed its total assets under management; independent estimates place its balance-sheet scale at roughly $88 million (Altss estimate). The management structure is lean, with no separate investment professionals listed beyond the corporate parent's leadership. The firm's capital base is corporate-bankrolled rather than third-party institutional commitments, making it a captive allocator for Chorokbaem Group's off-media investments. Metacare's architecture is unusual — a corporate investor nested within a publicly traded media group, directing retained earnings into hard healthcare assets rather than financial-portfolio strategies. This hybrid structure gives it patient capital without LP redemption pressure, though it also ties its fate to the parent group's governance and the operational performance of a concentrated set of hospital properties.